Cancer Imaging operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
All manuscripts are assessed and handled by the appropriate Section Editor. After an initial screening for general suitability, submissions are sent to at least two experts in the field who are asked to evaluate whether the manuscript is scientifically sound and coherent and whether the manuscript should be accepted, rejected or revised. Final decisions are made by the Editors-in-Chief based on the recommendations of Section Editors and reviewer reports.
The journal aims to provide authors with a first decision (accepted/rejected/revisions needed) within six weeks.